文献类型：期刊文献

中文题名：平胃胶囊的小鼠急性毒理学研究

英文题名：The Acute Toxicology Research of Pingwei Capsule on Mice

作者：毛兰芳[1];汪龙德[2];刘俊宏[2];张宏伟[1];杜晓娟[1];梁乾坤[3];李云霞[3]

第一作者：毛兰芳

机构：[1]甘肃中医学院,甘肃兰州730020;[2]甘肃中医学院附属医院,甘肃兰州730000;[3]兰州大学,甘肃兰州730000

第一机构：甘肃中医药大学

年份：2015

卷号：24

期号：7

起止页码：1129

中文期刊名：中国中医急症

外文期刊名：Journal of Emergency in Traditional Chinese Medicine

收录：CSTPCD

基金：国家自然科学基金项目(81360540);甘肃省中药药理与毒理学重点实验室项目(ZDSYS-KJ-2013-003);甘肃省中医药管理局项目(GZK-2012-31)

语种：中文

中文关键词：平胃胶囊;急性毒理学;研究

外文关键词：Pinswei Capsule ; Acute toxicology; Research

摘要：目的观察平胃胶囊临床用药的安全性。方法以昆明小鼠40只随机分为对照组和给药组,每组20只,雌雄各半。给药组给予平胃胶囊混悬液1 m L灌胃,对照组给予等量生理盐水灌胃,各组每日均连续灌胃5次。灌胃结束后观察一般情况和体质量变化,连续观察14 d后处死,检测血清肝肾功能和脏器指数,采用HE染色鉴别两组小鼠组织病理学差异。结果观察期间给药组小鼠均未出现中毒反应及死亡,两组小鼠体质量、脏器指数均无明显差异性变化(P>0.05);主要脏器大体标本颜色、形态未见明显异常改变,肝、肾、胃等组织HE染色无变性、炎症、坏死等改变;两组血清肝肾功能指标无明显差异(P>0.05)。结论小鼠每日最大给药量为150 kg/d,相当于临床每日用量的125倍(>100倍),表明平胃胶囊临床剂量服用安全。
Objective： To study the clinical safety of the Pingwei Capsule. Methods： 40 Kunming mice were randomly divided into the control group and the administration group, 10 males and 10 females in each group. The administration group were given 1 mL mixed suspension of Pingwei Capsule by garage,while the control group were given equal normal saline by gavage,5 times a day for each group. After it,the general situation and the change of body mass were observed. The mice were executed after 14 day continuous observation. Serum and re- nal function index and the index of viscera were detected. Differences in histopathology were identified with HE staining. Results： During administration,the mice in the administration group were not poisoned and died. The changes of the body mass and viscera index were not significantly different （P〉 0.05）. The color and shape of main organs gross specimen had no obvious abnormal change. HE staining of liver, kidney, stomach and other or- gans had no change, inflammation and necrosis. Serum and renal function index of the two group had no obvious difference （P〉 0.05）. Conclusion： Maximum daily dosage of the mice is 150 kg/d,equal to 125 times of clinical daily dosage（〉 100 times）,which indicates that the Pingwei Capsule has clinical safety.